The patient has an infection that would have been easy to fight with antibiotics two decades ago. But now that antibiotic-resistant bacteria are widespread, this formerly simple infection could be life-threatening. Cheemeng Tan, of Carnegie Mellon鈥檚 , is working on a solution: artificial cells that slow the growth of these drug-resistant bacteria. That work was recently honored with one of eight worldwide , which support research that combines science with social responsibility.
鈥擫orelei Laird (DC鈥�01)
Related Links:
Prestigious Swiss Fellowship Awarded to Lane Center's Cheemeng Tan
